Latest News for: ataxia

Edit

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia

Enid News & Eagle 07 Apr 2025
Participants with abnormal left ventricular mass index (LVMI) at baseline achieved 25% mean reduction in LVMI by 12 months or sooner ... .
Edit

Solaxa Announces Phase 3 Clinical Trial for Spinocerebellar Ataxia Type 27B

ACCESSWIRE 29 Mar 2025
Solaxa will serve as the regulatory sponsor of the trial and partner with leading ataxia centers of excellence ... There are currently no FDA approved therapies for SCA27B, a rare hereditary ataxia.
Edit

Living with Friedreich’s Ataxia: The loneliness of losing control

Canoe 25 Mar 2025
Eventually, they came to a formal and accurate diagnosis of Friedreich’s ataxia (FA), a rare progressive neurodegenerative disease that causes impaired muscle control due to nervous system damage ... Growing up with Friedreich’s ataxia.
  • 1
×